D. Traini
Feb 22, 2013
Citations
1
Influential Citations
19
Citations
Journal
Journal name not available for this finding
Abstract
Bend Research has developed an inhalation drug-delivery platform based on engineered particles. This broadly applicable technology: reproducibly delivers a high-fraction dose, enables delivery of challenging drug forms, improves combination therapies, and offers excellent physical stability (e.g., resistant to humidity and temperature), enables rapid progression to proof of concept (POC).while sparing bulk compound.